SHARE

News Alert: Citius Pharmaceuticals Receives FDA Approval For LYMPHIR™ (Denileukin Diftitox-Cxdl) Immunotherapy For The Treatment Of Adults With Relapsed Or Refractory Cutaneous T-Cell Lymphoma. Click to Read More.

Medical Marijuana Inc (OTCMKTS:MJNA) stated that its portfolio segment, HempMeds received shelf stability acceptance from the “Denver Public Health Department.” Its Gold Hemp and RSHO Blue brands were affirmed as appropriate as potentially harmless items that do not call for temperature or time control. The subsidiary will need to give a copy of the letter when it ships its products to retailers in Denver. It is an integral part of protocol that needs to be followed by the company.

The management comments

Marcos Agramont, the Operations Manager of HempMeds, expressed that they appreciate initiatives of Denver in acknowledging RSHO as a food item. The stability of food items and packaging of RSHO encouraged Denver to provide shelf stability to the products. The state said that there is no refrigeration required for on-shelf exhibit of Medical Marijuana’s unopened tubes. It gives the flexibility to approved retailers to promote RSHO on open shelves against a refrigerated display market. The acceptance opens new marketing network for Medical Marijuana as it will be able to sell its product to an extended number of retailers.

The significance

Safety and product quality are two important pillars of Medical Marijuana. The company considers them as strong base for creating its reputation. It also enhances the reliability of its portfolio investments, brands and clients. The company follows a rigorous testing process in which the hemp oil quality is assessed by two different cannabis and food testing labs, with qualifications including A2LA: ISO/IEC 17025, VASP, FSIS approved labs, USDA supported lab and even ASTA check sample program. The testing lab should be ISO recognized for nutritional analyses. The batch number of products is matched; findings are checked and then approved for production.

In last trading session, the share price of Medical Marijuana Inc (OTCMKTS:MJNA) declined consolidated and closed flat at $0.0770.The traded share volume was 2.56 million compared to average share volume of 6.71 million.